Edward Lifesciences pays Boston Scientific $180 million to end patent row
By Manas Mishra (Reuters) – Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers. Boston Scientific...
Read More